Vertex (VRTX) CSO Mark Bunnage disposes shares for tax withholding

Rhea-AI Filing Summary

Vertex Pharmaceuticals executive Mark E. Bunnage reported a tax-related share disposition. On this Form 4, he disposed of 2,283 shares of common stock at a price of $487.76 per share in a transaction coded "F," which represents payment of a tax liability by delivering shares, not an open-market sale. After this transaction, he directly owns 10,631 shares of Vertex common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bunnage Mark E.

Role EVP, Chief Scientific Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	2,283	$487.76	$1.11M

Holdings After Transaction: Common Stock — 10,631 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bunnage Mark E.

(Last) (First) (Middle)

C/O VERTEX PHARMACEUTICALS INCORPORATED

50 NORTHERN AVENUE

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Scientific Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		2,283	D	$487.76	10,631	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Christiana Stevenson, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vertex (VRTX) report for Mark E. Bunnage?

Vertex EVP and Chief Scientific Officer Mark E. Bunnage reported a Form 4 tax-related disposition of 2,283 shares of common stock. The transaction was coded “F,” indicating shares were delivered to cover a tax obligation rather than sold in the open market.

How many Vertex (VRTX) shares did Mark E. Bunnage dispose of and at what price?

Mark E. Bunnage disposed of 2,283 shares of Vertex common stock at a price of $487.76 per share. The filing identifies the transaction as a tax-withholding event, not a traditional open-market sale of shares for investment purposes.

What does transaction code “F” mean in the Vertex (VRTX) Form 4 filing?

Transaction code “F” means the shares were used to pay an exercise price or tax liability by delivering securities. In this Vertex filing, it signifies Mark E. Bunnage’s disposition of shares was for tax withholding, distinguishing it from a discretionary market sale.

How many Vertex (VRTX) shares does Mark E. Bunnage own after this Form 4 transaction?

After the reported tax-withholding disposition, Mark E. Bunnage directly owns 10,631 shares of Vertex common stock. This post-transaction holding figure is disclosed explicitly in the Form 4 as “total shares following transaction” for his direct ownership.

Was the Vertex (VRTX) insider transaction a buy or sell by Mark E. Bunnage?

The Form 4 classifies the transaction as a disposition related to tax withholding, not a regular buy or sell. Code “F” and the description show shares were delivered to satisfy a tax liability, rather than being sold on the open market for investment reasons.